Evidence-based and tailored medication in type 2 diabetes: a pathway learned from clinical trials

DOI: 10.1186/s12933-019-0834-0

Keywords: Type 2 diabetes, Cardiovascular outcome trial, Glucose-lowering agent, Dipeptidyl peptidase-4 inhibitor, Tailored medication

Full-Text   Cite this paper   Add to My Lib

Abstract:

The pathway from clinical trials to selecting tailored medication for patients with type 2 diabete

Full-Text